Neonatal Abstinence Syndrome: Twins Case Series
نویسندگان
چکیده
Background Use or abuse of opioids and related drugs during pregnancy increases the risk of maternal and neonatal morbidities, including increased susceptibility to Neonatal Abstinence Syndrome (NAS). Severity of NAS is determined by both environmental and genetic factors, but the level of influence each one of them has in determining the severity of NAS is not fully understood. Since the incidence and severity of NAS vary a lot among susceptible infants, twin studies might give us valuable insights into understanding the relative roles of environmental and genetic factors at the onset of the disease and during its progression. Higher concordance of occurrence and severity of NAS in monozygotic twins compared to dizygotic twins would suggest a genetic role in the pathogenesis of NAS. However, comparable concordance suggests a non-genetic or an environmental basis. In this case series, we report neonatal outcomes including severity of NAS among monozygotic and dizygotic twins. Methods A retrospective chart review was performed for all newborn twins who were at risk of developing NAS, were born in our institution between January 2006 and December 2014, and had a gestational age of 30 weeks or greater. Results During the study period, we identified seven sets (total of 14 infants) of eligible twins, comprising six dizygotic and one monozygotic twins, from a total of 550 infants who were at risk of developing NAS. Among the seven sets of twins, two sets were concordant for severe NAS and required pharmacological management, three sets of twins were concordant in not having severe NAS and did not require pharmacological management, and the remaining two sets were discordant, where one of the twins required pharmacological treatment. Conclusion Five of the seven sets of twins in our study exhibited concordance and two sets showed discordance in withdrawal severity. Larger studies may help in understanding the roles of genetic and environmental factors in determining the severity of NAS.
منابع مشابه
A Case Report of Newborn with Thrombocytosis Born to an Opioid-addict Mother
Neonatal thrombocytosis is a very rare phenomenon in infants born to addict mothers. It can be due to opioids withdrawal and occurs a few days after delivery. The etiology is unknown and it is eradicated gradually without any complication. The reported neonate was born to a heroin addict mother who has used methadone during pregnancy. The neonate was admitted in 14th day of life in neonatal int...
متن کاملNeonatal Abstinence Syndrome (NAS; Neonatal Withdrawal) — Pathophysiology and Treatment
Neonatal abstinence syndrome is characterized by the onset of withdrawal symptoms in a neonate due to prenatal or postnatal exposure to illegal drugs or prescription drugs. The clinical presentation is usually dependent on the duration and time of exposure to the drug and not the drug itself. Meconium analysis or umbilical cord testing are the gold standard for the diagnosis of neonatal abstine...
متن کاملNeonatal abstinence syndrome due to codeine.
The neonatal abstinence syndrome (NAS) is a potentially life threatening illness associated with significant morbidity especially in the neonatal period. A case of NAS due to codeine prescribed for pain relief during pregnancy is reported. Clinicians should be aware that narcotic derivatives prescribed in late pregnancy can give rise to this type of problem.
متن کاملNeonatal Abstinence Syndrome due to In-utero Exposure to Gabapentin: A Case Report
We report the case of a neonate who likely developed symptoms of Neonatal Abstinence Syndrome after in-utero exposure to gabapentin for treatment of maternal chronic pain. The neonate developed symptoms of hypertonicity, tremor, and poor feeding twelve hours after delivery. Although the neonate wasbriefly exposed to the benzodiazepine alprazolam and the opioid oxycodone, the withdrawal symptoms...
متن کاملSafety, Tolerability, and Efficacy of Acupuncture in Management of Neonatal Abstinence Syndrome (NAS): A Systematic Review
Background: The Neonatal Abstinence Syndrome (NAS) has been treated so far by various drugs, such as opioids and non-opioids. There is some concern about NAS babies who receive chemical drug treatment. Some researchers mentioned that shorter pharmacological treatment and less lengthy hospitalization are associated with severa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 5 شماره
صفحات -
تاریخ انتشار 2017